Changes to Pre-Approval Process by Major Insurance Companies
In light of recent developments, a commitment has been made to expedite and simplify advance approvals in the health insurance sector. This decision was announced on Monday by major U.S. health plans.
Advance approval, or pre-approval, allows healthcare providers to secure permission from a patient’s insurance before delivering specific treatments. While insurance companies argue that this process helps to guarantee that patients get necessary care while managing costs, there has been significant criticism from patients and providers alike. Delays or rejections of care, along with increased burnout among doctors, have been highlighted as major concerns.
Several large insurance companies—including CVS Health, UnitedHealthcare, Cigna, Humana, and Elevance Health—are now taking steps to improve the situation. According to the America’s Health Insurance Plans (AHIP), which represents these health plans, initiatives are underway to enhance patient access to care and alleviate some of the burdens on healthcare providers.
This overhaul will introduce broad changes across market segments, affecting commercial coverages and Medicare and Medicaid plans. The anticipated outcomes are significant, with hopes that it will help nearly 257 million Americans.
This decision comes after the U.S. health insurance sector faced intense public scrutiny following the tragic death of UnitedHealthcare’s executive, Brian Thompson. There has been a growing push to reform the pre-authorization process, and various companies have already begun this work.
Looking ahead, some of the proposed changes might include setting common standards for electronic pre-approval requests by 2027. The goal is for 80% of these electronic approvals—along with all necessary clinical documentation—to be processed in real time by then.
In efforts to streamline operations and reduce workloads for doctors and medical facilities, individual plans are also expected to limit the types of claims that will require advance approval by 2026.
Sean Martin, CEO of the American Academy of Family Physicians, expressed optimism, saying they look forward to collaborating with payers to ensure these initiatives create lasting improvements in patient care.
